• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by P3 Health Partners Inc. (Amendment)

    2/13/24 5:12:03 PM ET
    $PIII
    Medical/Nursing Services
    Health Care
    Get the next $PIII alert in real time by email
    SC 13G/A 1 tv01643-p3healthpartnersincc.htm SCHEDULE 13G/A p3healthpartnersincclassa

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 2)*

    Name of issuer:  P3 Health Partners Inc. Class A

    Title of Class of Securities:  Common Stock

    CUSIP Number:  744413105

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  744413105

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    65,970

    7.  SOLE DISPOSITIVE POWER

    1,479,280

    8.  SHARED DISPOSITIVE POWER

    81,375

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,560,655

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    1.35%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    P3 Health Partners Inc. Class A

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    2370 Corporate Circle, Suite 300
    Henderson, NV 89074

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    744413105

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $PIII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PIII

    DatePrice TargetRatingAnalyst
    8/28/2025$20.00Buy
    Lake Street
    4/1/2024Buy → Neutral
    BTIG Research
    9/1/2023$5.00Buy
    BTIG Research
    6/30/2023Market Perform
    TD Cowen
    1/4/2022Outperform
    William Blair
    More analyst ratings

    $PIII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

    GREENWOOD VILLAGE, Colo., Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025. P3 Health Partners is a population health management organization that supports providers with administrative services and care coordination for Medicare members. This milestone marks a significant achievement in Catalyst's work to help P3 deliver high-quality, efficient service to members across a multi-state footprint. P3 operates in Arizona, Oregon, N

    8/25/25 9:30:00 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Announces Second Quarter 2025 Results

    Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head

    8/14/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 14, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th

    7/31/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/13/24 9:56:09 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $128,624 worth of shares (240,000 units at $0.54) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/12/24 8:12:24 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $117,544 worth of shares (240,000 units at $0.49) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/11/24 6:17:20 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $PIII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $PIII
    SEC Filings

    View All

    Lake Street resumed coverage on P3 Health Partners with a new price target

    Lake Street resumed coverage of P3 Health Partners with a rating of Buy and set a new price target of $20.00

    8/28/25 8:10:21 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners downgraded by BTIG Research

    BTIG Research downgraded P3 Health Partners from Buy to Neutral

    4/1/24 7:39:12 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on P3 Health Partners with a new price target

    BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00

    9/1/23 7:31:24 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Director Kazarian Gregory N. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 218,561 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:27:25 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Director Tolan Mary A was granted 2,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 218,561 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:23:20 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Director Thierer Mark was granted 4,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 437,121 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:18:03 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - P3 Health Partners Inc. (0001832511) (Filer)

    8/29/25 4:17:12 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by P3 Health Partners Inc.

    10-Q - P3 Health Partners Inc. (0001832511) (Filer)

    8/14/25 4:56:15 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - P3 Health Partners Inc. (0001832511) (Filer)

    8/14/25 4:07:52 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Leadership Updates

    Live Leadership Updates

    View All

    P3 Health Partners Names Leif Pedersen New Chief Financial Officer

    P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m

    8/29/24 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Names Dr. Aric Coffman as CEO

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici

    5/8/24 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Financials

    Live finance-specific insights

    View All

    P3 Health Partners Announces Second Quarter 2025 Results

    Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head

    8/14/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Second Quarter Earnings Conference Call Date & Time August 14, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into th

    7/31/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Announces First Quarter 2025 Results

     Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2025, and affirmed its 2025 guidance. "Our physician-led care enablement model continues to differentiate P3, delivering meaningful improvements in quality measures and cost management through deeper provider partnerships," said Aric Coffman, CEO of P3. "Our turnaround plan is ahead of schedule, with three of four markets already achieving breakeven or better in Q1. Beyond our ori

    5/15/25 4:18:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by P3 Health Partners Inc.

    SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

    11/14/24 4:33:46 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

    SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

    11/8/24 5:15:05 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

    SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

    6/26/24 4:30:49 PM ET
    $PIII
    Medical/Nursing Services
    Health Care